대한한의학방제학회지 (Herbal Formula Science)

  • 제25권3호
  • /
  • Pages.349-362
  • /
  • 2017
  • /
  • 1229-1218(pISSN)
  • /
  • 2288-5641(eISSN)
대한한의학방제학회 (The Korean Medicine Society for the Herbal Formula Study)
권호 표지
DOI QR코드

DOI QR Code

저근백피(樗根白皮) 추출물에 의한 급성 림프성 백혈병 Jurkat Lymphocytes의 세포고사 유도 및 신호기전 연구

Study of Signaling Pathway on Apoptotic Cell Death Induced by Extract of Ailanthus altissima in Human Jurkat Lymphocytes

  • Lee, Ki Ouk (Graduate School of Wonkwang University) ;
  • Kim, Ae Wha (Graduate School of Wonkwang University) ;
  • Lim, Kyu Sang (Professional Graduate School of Korean Medicine, Wonkwang University) ;
  • Yun, Young Gab (Graduate School of Wonkwang University)
  • 투고 : 2017.08.17
  • 심사 : 2017.08.30
  • 발행 : 2017.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives : We investigated whether the components of Ailanthus altissima induced apoptotic cell death in Jurkat acute lymphoblastic leukemia (ALL) cells. Methods : Regulation of cell proliferation is a complex process involving the regulated expression and/or modification of discrete gene products, which control transition between different stages of the cell cycle. Results : Upon treatments with Ailanthus altissima, the concentration-dependent inhibitions of cell viability were observed as compared to untreated control group. The capability of Ailanthus altissima to induce apoptosis was associated with proteolytic cleavage of specific target proteins such as poly(ADP-ribose)polymerase (PARP) and beta-catenin proteins suggesting the possible involvement of caspases. Ailanthus altissima also caused apoptosis as measured by cell morphology and DNA fragmentation. Conclusions : These results indicate that the increase of apoptotic cell death by Ailanthus altissima may be due to the inhibition of cell cycle in human Jurkat lymphocytes. Conclusively, these current and further findings will provide novel approaches to understanding and treating major diseases.

키워드

참고문헌

  1. Oriental medicine dictionary editing committee. Supplemental Oriental medicine dictionary, Seoul, Jeongdam, 1998:1354.
  2. Kim JS. Standard Galenicalpharmacy, Seoul, Jinmyung publishing company, 1975:353.
  3. Ouh ER. Bonchoujongshin, Seoul, Hanglimseswon, 1972:120.
  4. Mun G et al. East & West Combine Treatment of Cancer II, Iksan, Wonkwang Univ, 1999:741-93.
  5. Chung BS et al. Illustrated Herb dictionary, Seoul Youngrimsa, 1990:775-7.
  6. Gae WB. Pharmacology & application of Anticancer Herb, Harbin, Hukrunggang Science technology publishing company, 1999:1200, 1268-9.
  7. Oriental Herb dictionary editing committee. Supplemental Oriental Herb dictionary(8), Seoul, Jeongdam, 1997:3711-4.
  8. Shin KG. Shinssi Hebal Medicine, Seoul, Sumunsa, 1982:160-1.
  9. Lee SJ. Bonchougangmok, Beijing, Human Health publishing company, 1988:1987-91.
  10. Shin MG. Clinical Galenicalpharmacy, Seoul, Youngrimsa, 1988:591-592.
  11. Chai YM. New Pharmacology & application of Chinese Herb, Beijing, Hwaha publishing company, 1999:521.
  12. Rae JK et al. Chinese Clinical Galenicalpharmacy(ha), Beijing, Human Health publishing company, 1998:1856-8.
  13. Pathology Society of Korea. Pathology, Seoul, Komunsa, 1990:179-86.
  14. Bang YJ. Practical Chinese internalmedicine, Shanghai, Shanghai science technology publishing company, 1986:12-6, 621-35.
  15. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.Cancer Res, 1993:53:3979-85.
  16. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. J. Biol. Chem. 1998:273:1-4. https://doi.org/10.1074/jbc.273.1.1
  17. Korean Health Organization. : Korean herb standard book, Seoul, 1984:111.
  18. Gangsou New medicine academy. Chinese Herb dictionary I(ha), Shanghai, Shanghai science technology publishing company, 1979:2587-9.
  19. Tang W, Eisenbrand G. Chinese drugs of plant origin.Springer-Verlag, New York, 1992:51-7.
  20. Martin SJ et al. Proteolysis of fodrin (nonerythroid spectrin) during apoptosis. J. Biol. Chem, 1995:270:6425-8.
  21. Alnemri ES et al. Human ICE/CED-3 protease nomenclature. Cell, 1996:87:171. https://doi.org/10.1016/S0092-8674(00)81334-3
  22. Hwang SG et al. Proteolysis of beta-catenin in apoptotic Jurkat cells. Journal of Life Science, 2000:10:57-63.
  23. Bicknell GR, Snowden RT, Cohen GM. Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukemic cell line. U937. J. Cell Sci, 1994:107:2483-9.
  24. Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclindependent kinase inhibitors (CKIs). Oncogene, 1995:11:211-19.
  25. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 nheterodimerizes in vivo with a conserved homolog, Bax, thataccelerates programmed cell death. Cell, 1993:74:609-619. https://doi.org/10.1016/0092-8674(93)90509-O
  26. Driks PB, Rutka JT. Current concepts in neurooncology: thecell cycle. Neurosurgery, 1997:40: 1000-13. https://doi.org/10.1097/00006123-199705000-00025
  27. Serrano M, Hannon GJ, Beach D. A new regulatory motif incell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 1993:366:704-7. https://doi.org/10.1038/366704a0
  28. Baek HR. Byunjeongshidhi outline, Unnam, Human publishing company, 1984:502.
  29. Ashall F, Bramwell ME, Harris H. A new marker for humancancer cells. Lancet, 1982:2:1-6.
  30. Suffness M, Douros J. Current status of the NCI plant and animal product program. J. Nat. Prod, 1982:45:1-14. https://doi.org/10.1021/np50019a001
  31. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol, 1991:139:271-9.
  32. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification ofprogrammed cell death in situ via specific labeling of nuclear DNAfragmentation. J. Cell Bio, 1992:119:493-501. https://doi.org/10.1083/jcb.119.3.493
  33. Wang JY, Knudsen ES, Welch PJ. The retinoblastoma tumor suppressor protein. Adv. Cancer Res, 1994:64:25-85.
  34. Ruddon RW. Chemical carcinogenesis. In principles of drug action (3rd.), Churchill Livingstone, 1999:735.
  35. Son GW. Chinese Treatment of Leukemia, Hongkong, Haebong publishing company, 1990:112-3.
  36. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell Biol, 1995:15:2612-24. https://doi.org/10.1128/MCB.15.5.2612
  37. An WG, Hwang SG, Trepel JB, Blagosklonny MV. Protease inhibitor -induced apoptosis: accumulation wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers ofproteasome inhibition. Leukemia, 2000:14:1276-83. https://doi.org/10.1038/sj.leu.2401812
  38. School of Medicine Seoul national univ. Oncology, Seoul national univ publishing part, 1992:1-3, 78-90, 137-43, 225-34.
  39. Moran P. Cellular effects of cancer chemotherapy administration. J. Intraven. Nurs, 2000:23:44-51.